Cargando…

30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival

Objective: to analyze the evolution of surgical techniques and strategies, and to determine their influence on the survival of patients with stage III or IV epithelial ovarian cancer (EOC). Methods: a retrospective data analysis was performed in two French tertiary cancer institutes. The analysis in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delga, Berenice, Classe, Jean-Marc, Houvenaeghel, Gilles, Blache, Guillaume, Sabiani, Laura, El Hajj, Houssein, Andrieux, Nicole, Lambaudie, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140106/ https://www.ncbi.nlm.nih.gov/pubmed/32213920 http://dx.doi.org/10.3390/cancers12030768

Ejemplares similares

Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
por: Blache, Guillaume, et al.
Publicado: (2021)

Transperitoneal para-aortic lymphadenectomy by robot assisted laparoscopy in 10 steps
por: Heinemann, Mellie, et al.
Publicado: (2019)

Choosing the most appropriate minimally invasive approach to treat gynecologic cancers in the context of an enhanced recovery program: Insights from a comprehensive cancer center
por: Netter, Antoine, et al.
Publicado: (2020)

Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Enhanced Recovery after Surgery and Endometrial Cancers: Results from an Initial Experience Focused on Elderly Patients
por: Miguet, Céline, et al.
Publicado: (2023)

Robotic Versus Conventional Nipple-Sparing Mastectomy With Immediate Breast Reconstruction
por: Houvenaeghel, Gilles, et al.
Publicado: (2021)

Mastectomy with immediate breast reconstruction: Results of a mono-centric 4-years cohort
por: Quilichini, Olivia, et al.
Publicado: (2020)

Enhanced recovery after surgery program in Gynaecologic Oncological surgery in a minimally invasive techniques expert center
por: Lambaudie, Eric, et al.
Publicado: (2017)

Early clinical outcomes of hybrid brachytherapy for locally advanced cervical cancer: making adverse situations in a favorable scenario
por: Cagetti, Leonel Varela, et al.
Publicado: (2022)

Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer
por: Eo, Wankyu, et al.
Publicado: (2016)

Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramifications
por: de Jong, Diederick, et al.
Publicado: (2023)

Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III–IV epithelial ovarian cancer
por: Iwagoi, Yutaka, et al.
Publicado: (2021)

Types of Mastectomies and Immediate Reconstructions for Ipsilateral Breast Local Recurrences
por: Simon, Pauline, et al.
Publicado: (2020)

Development of a mucinous adenocarcinoma on a sigmoid colpoplasty for vaginal agenesis: About a case report and review of the literature
por: Christophe, Marie, et al.
Publicado: (2021)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
por: Dabi, Yohann, et al.
Publicado: (2020)

A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
por: Métairie, Marie, et al.
Publicado: (2023)

Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer
por: Digklia, Antonia, et al.
Publicado: (2014)

Skin sparing mastectomy and robotic latissimus dorsi-flap reconstruction through a single incision
por: Houvenaeghel, Gilles, et al.
Publicado: (2019)

Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)

Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy
por: Brun, Jean-Luc, et al.
Publicado: (2009)

Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer
por: Llueca, Antoni, et al.
Publicado: (2018)

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival
por: Houvenaeghel, G, et al.
Publicado: (2016)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
por: Wei, Xuan, et al.
Publicado: (2023)

Characteristics of patients with stage III and IV ovarian endometriomas and trends in postoperative anti-Mullerian hormone changes
por: Gao, Kefei, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in FIGO Stage III and IV Epithelial Ovarian, Tubal or Peritoneal Cancer: A Systematic Review and Meta-Analysis
por: Tzanis, Alexander A., et al.
Publicado: (2022)

NIPEC with Single-Dose Intraperitoneal Cisplatin and Paclitaxel in Stage III Epithelial Ovarian Cancer
por: Saldanha, Elroy, et al.
Publicado: (2022)

A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV
por: Dai-yuan, Ma, et al.
Publicado: (2013)

Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints
por: Hudry, Delphine, et al.
Publicado: (2022)

Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis
por: Chang, Yen-Hou, et al.
Publicado: (2016)

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
por: Los-de Vries, G. Tjitske, et al.
Publicado: (2022)

Positive or close margins: reoperation rate and second conservative resection or total mastectomy?
por: Houvenaeghel, Gilles, et al.
Publicado: (2019)

Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer
por: Lei, Ziying, et al.
Publicado: (2020)

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
por: Sørensen, Sarah Mejer, et al.
Publicado: (2022)

Mastectomy and Immediate Breast Reconstruction with Pre-Pectoral or Sub-Pectoral Implant: Assessing Clinical Practice, Post-Surgical Outcomes, Patient’s Satisfaction and Cost
por: Houvenaeghel, Gilles, et al.
Publicado: (2022)

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute
por: Hainsworth, John D, et al.
Publicado: (2015)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2013)

Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer
por: Forde, Gareth K, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t2nnujtipqi9q1i8ic4jsh8krh